4//SEC Filing
Maxwell John T. 4
Accession 0001214659-20-002751
CIK 0001398733other
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 4:47 PM ET
Size
5.4 KB
Accession
0001214659-20-002751
Insider Transaction Report
Form 4
Maxwell John T.
SVP-Chief Financial Officer
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2020-03-16+60,000→ 60,000 totalExercise: $1.54Exp: 2030-03-16→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]The units subject to the Award shall vest 25% 1st year, 25% 2nd year and 50% 3rd year on the commencement anniversaries.
Documents
Issuer
Aquestive Therapeutics, Inc.
CIK 0001398733
Entity typeother
Related Parties
1- filerCIK 0001739025
Filing Metadata
- Form type
- 4
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 4:47 PM ET
- Size
- 5.4 KB